| Id |
Subject |
Object |
Predicate |
Lexical cue |
| 11964077-0#0#13#gene3576 |
392-756 |
gene3576 |
denotes |
In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8 |
| 11964077-4#85#113#diseaseC1514428 |
639-667 |
diseaseC1514428 |
denotes |
primary peritoneal carcinoma |
| 11964077-4#189#202#gene3576 |
743-756 |
gene3576 |
denotes |
interleukin-8 |
| 11964077-0#18#52#gene7422 |
769-803 |
gene7422 |
denotes |
vascular endothelial growth factor |
| 11964077-4#215#249#gene7422 |
769-803 |
gene7422 |
denotes |
vascular endothelial growth factor |
| 11964077-4#251#255#gene7422 |
805-809 |
gene7422 |
denotes |
VEGF |
| 11964077-0#99#116#diseaseC0029925 |
1491-2105 |
diseaseC0029925 |
denotes |
of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila |
| 11964077-0#99#116#diseaseC0677886 |
1491-2105 |
diseaseC0677886 |
denotes |
of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila |
| 11964077-0#99#116#diseaseC0029925 |
1491-2105 |
diseaseC0029925 |
denotes |
of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila |
| 11964077-0#99#116#diseaseC0677886 |
1491-2105 |
diseaseC0677886 |
denotes |
of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila |
| 11964077-10#74#78#gene7422 |
1494-1498 |
gene7422 |
denotes |
VEGF |
| 11964077-10#135#145#diseaseC0027627 |
1555-1565 |
diseaseC0027627 |
denotes |
metastases |
| 11964077-11#0#4#gene3576 |
1579-1583 |
gene3576 |
denotes |
IL-8 |
| 11964077-11#71#81#diseaseC0027627 |
1650-1660 |
diseaseC0027627 |
denotes |
metastases |
| 11964077-17#31#43#diseaseC0280100 |
2260-2272 |
diseaseC0280100 |
denotes |
solid tumors |
| 11964077-17#31#43#diseaseC0280100 |
2260-2272 |
diseaseC0280100 |
denotes |
solid tumors |
| 11964077-17#31#43#diseaseC0280100 |
2260-2272 |
diseaseC0280100 |
denotes |
solid tumors |
| 11964077-17#72#76#gene3576 |
2301-2305 |
gene3576 |
denotes |
IL-8 |
| 11964077-17#81#85#gene7422 |
2310-2314 |
gene7422 |
denotes |
VEGF |
| 11964077-17#217#221#gene7422 |
2446-2450 |
gene7422 |
denotes |
VEGF |
| 11964077-17#233#237#gene3576 |
2462-2466 |
gene3576 |
denotes |
IL-8 |
| 11964077-17#303#326#diseaseC0280220 |
2532-2555 |
diseaseC0280220 |
denotes |
stage ovarian carcinoma |
| 11964077-17#303#326#diseaseC0280220 |
2532-2555 |
diseaseC0280220 |
denotes |
stage ovarian carcinoma |
| 11964077-17#303#326#diseaseC0280220 |
2532-2555 |
diseaseC0280220 |
denotes |
stage ovarian carcinoma |
| 0#13#gene357699#116#diseaseC0029925 |
11964077-0#0#13#gene3576 |
11964077-0#99#116#diseaseC0029925 |
associated_with |
"In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 0#13#gene357699#116#diseaseC0029925 |
11964077-0#0#13#gene3576 |
11964077-0#99#116#diseaseC0029925 |
associated_with |
"In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 0#13#gene357699#116#diseaseC0677886 |
11964077-0#0#13#gene3576 |
11964077-0#99#116#diseaseC0677886 |
associated_with |
"In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 0#13#gene357699#116#diseaseC0677886 |
11964077-0#0#13#gene3576 |
11964077-0#99#116#diseaseC0677886 |
associated_with |
"In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 0#4#gene357671#81#diseaseC0027627 |
11964077-11#0#4#gene3576 |
11964077-11#71#81#diseaseC0027627 |
associated_with |
IL-8,metastases |
| 18#52#gene742299#116#diseaseC0029925 |
11964077-0#18#52#gene7422 |
11964077-0#99#116#diseaseC0029925 |
associated_with |
vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 18#52#gene742299#116#diseaseC0029925 |
11964077-0#18#52#gene7422 |
11964077-0#99#116#diseaseC0029925 |
associated_with |
vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 18#52#gene742299#116#diseaseC0677886 |
11964077-0#18#52#gene7422 |
11964077-0#99#116#diseaseC0677886 |
associated_with |
vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 18#52#gene742299#116#diseaseC0677886 |
11964077-0#18#52#gene7422 |
11964077-0#99#116#diseaseC0677886 |
associated_with |
vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila" |
| 189#202#gene357685#113#diseaseC1514428 |
11964077-4#189#202#gene3576 |
11964077-4#85#113#diseaseC1514428 |
associated_with |
interleukin-8,primary peritoneal carcinoma |
| 215#249#gene742285#113#diseaseC1514428 |
11964077-4#215#249#gene7422 |
11964077-4#85#113#diseaseC1514428 |
associated_with |
vascular endothelial growth factor,primary peritoneal carcinoma |
| 217#221#gene7422303#326#diseaseC0280220 |
11964077-17#217#221#gene7422 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
VEGF,stage ovarian carcinoma |
| 217#221#gene7422303#326#diseaseC0280220 |
11964077-17#217#221#gene7422 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
VEGF,stage ovarian carcinoma |
| 217#221#gene7422303#326#diseaseC0280220 |
11964077-17#217#221#gene7422 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
VEGF,stage ovarian carcinoma |
| 217#221#gene742231#43#diseaseC0280100 |
11964077-17#217#221#gene7422 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
VEGF,solid tumors |
| 217#221#gene742231#43#diseaseC0280100 |
11964077-17#217#221#gene7422 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
VEGF,solid tumors |
| 217#221#gene742231#43#diseaseC0280100 |
11964077-17#217#221#gene7422 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
VEGF,solid tumors |
| 233#237#gene3576303#326#diseaseC0280220 |
11964077-17#233#237#gene3576 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
IL-8,stage ovarian carcinoma |
| 233#237#gene3576303#326#diseaseC0280220 |
11964077-17#233#237#gene3576 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
IL-8,stage ovarian carcinoma |
| 233#237#gene3576303#326#diseaseC0280220 |
11964077-17#233#237#gene3576 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
IL-8,stage ovarian carcinoma |
| 233#237#gene357631#43#diseaseC0280100 |
11964077-17#233#237#gene3576 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
IL-8,solid tumors |
| 233#237#gene357631#43#diseaseC0280100 |
11964077-17#233#237#gene3576 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
IL-8,solid tumors |
| 233#237#gene357631#43#diseaseC0280100 |
11964077-17#233#237#gene3576 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
IL-8,solid tumors |
| 251#255#gene742285#113#diseaseC1514428 |
11964077-4#251#255#gene7422 |
11964077-4#85#113#diseaseC1514428 |
associated_with |
VEGF,primary peritoneal carcinoma |
| 72#76#gene3576303#326#diseaseC0280220 |
11964077-17#72#76#gene3576 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
IL-8,stage ovarian carcinoma |
| 72#76#gene3576303#326#diseaseC0280220 |
11964077-17#72#76#gene3576 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
IL-8,stage ovarian carcinoma |
| 72#76#gene3576303#326#diseaseC0280220 |
11964077-17#72#76#gene3576 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
IL-8,stage ovarian carcinoma |
| 72#76#gene357631#43#diseaseC0280100 |
11964077-17#72#76#gene3576 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
IL-8,solid tumors |
| 72#76#gene357631#43#diseaseC0280100 |
11964077-17#72#76#gene3576 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
IL-8,solid tumors |
| 72#76#gene357631#43#diseaseC0280100 |
11964077-17#72#76#gene3576 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
IL-8,solid tumors |
| 74#78#gene7422135#145#diseaseC0027627 |
11964077-10#74#78#gene7422 |
11964077-10#135#145#diseaseC0027627 |
associated_with |
VEGF,metastases |
| 81#85#gene7422303#326#diseaseC0280220 |
11964077-17#81#85#gene7422 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
VEGF,stage ovarian carcinoma |
| 81#85#gene7422303#326#diseaseC0280220 |
11964077-17#81#85#gene7422 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
VEGF,stage ovarian carcinoma |
| 81#85#gene7422303#326#diseaseC0280220 |
11964077-17#81#85#gene7422 |
11964077-17#303#326#diseaseC0280220 |
associated_with |
VEGF,stage ovarian carcinoma |
| 81#85#gene742231#43#diseaseC0280100 |
11964077-17#81#85#gene7422 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
VEGF,solid tumors |
| 81#85#gene742231#43#diseaseC0280100 |
11964077-17#81#85#gene7422 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
VEGF,solid tumors |
| 81#85#gene742231#43#diseaseC0280100 |
11964077-17#81#85#gene7422 |
11964077-17#31#43#diseaseC0280100 |
associated_with |
VEGF,solid tumors |
